Late Humoral Rejection in a Cardiac Transplant Recipient Treated With the Anti-CD20 Monoclonal Antibody Rituximab

Transplantation Proceedings

Volumn 38, Issue 5, 2006, Pages 1520-1522

  Keren, A ^a   Hayes, H M ^a   O'Driscoll, G ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; B LYMPHOCYTE; CARDIAC GRAFT REJECTION; CASE REPORT; CYTOMEGALOVIRUS; DYSPNEA; EPSTEIN BARR VIRUS; FATIGUE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SALVAGE THERAPY; T LYMPHOCYTE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIGENS, CD20; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED;

EID: 33745184834     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.03.024     Document Type: Article

References (9)

1. Grauhan O., Knosalla C., Ewert R., et al. Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant 20 (2001) 316
2. Aranda Jr. J.M., Scornik J.C., Normann S.J., et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection. a case report. Transplantation 73 (2002) 907
3. Garrett Jr. H.E., Groshart K., Duvall-Seaman D., et al. Treatment of humoral rejection with rituximab. Ann Thorac Surg 74 (2002) 1240
4. Skoda-Smith S., Douglas V.K., Mehta P., et al. Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. Bone Marrow Transplant 2001 (2001) 329
5. Hammond E.H., Yowell R.L., Price G.D., et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 11 (1992) S111
6. Lones M.A., Czer L.S., Trento A., et al. Clinical-pathologic features of humoral rejection in cardiac allografts. a study in 81 consecutive patients. J Heart Lung Transplant 14 (1995) 151
7. Michaels P.J., Espejo M.L., Kobashigawa J., et al. Humoral rejection in cardiac transplantation. risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58
8. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation. pathologic observations and clinical implications. J Heart Lung Transplant 8 (1989) 430
9. Hagberg H., and Holmbom E. Risk factors for side effects during first infusion of rituximab-definition of a low risk group. Med Oncol 17 (2000) 218